Maverick Capital’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.18M Buy
+24,581
New +$1.15M 0.01% 127
2023
Q2
Sell
-8,634
Closed -$470K 533
2023
Q1
$470K Buy
8,634
+3,459
+67% +$168K 0.01% 288
2022
Q4
$251K Buy
+5,175
New +$227K 0.01% 336
2016
Q3
Sell
-42,790
Closed -$1.79M 152
2016
Q2
$1.79M Buy
+42,790
New +$1.75M 0.02% 89
2016
Q1
Sell
-91,300
Closed -$3.89M 149
2015
Q4
$3.89M Sell
91,300
-10,350
-10% -$476K 0.06% 38
2015
Q3
$4.83M Hold
101,650
0.08% 33
2015
Q2
$5.04M Buy
+101,650
New +$5.15M 0.08% 37

Other funds holding SNY

Maverick Capital's SNY Position: Q1 2026 in Review

Maverick Capital opened a new position in Sanofi (SNY) in Q1 2026: 24,581 shares worth $1.18M. The stake represents 0.01% of the portfolio and ranks #127 among its holdings. This is a return to the name: Maverick Capital previously reported a position in SNY as recently as Q1 2023.

Maverick Capital first reported a position in SNY in Q2 2015 and has held it in 7 quarters since. The position peaked at $5.04M in Q2 2015. 737 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

  • Maverick Capital held 24,581 shares of Sanofi worth $1.18M as of Q1 2026.
  • Sanofi was a new Maverick Capital position in Q1 2026.
  • Sanofi made up 0.01% of Maverick Capital's portfolio in Q1 2026, its #127 holding.
  • Maverick Capital first reported a position in Sanofi in Q2 2015 and has held it in 7 quarters since.
  • Maverick Capital's Sanofi position peaked at $5.04M in Q2 2015.
  • 737 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on Maverick Capital's 13F filing for Q1 2026, filed 15 May 2026.